Herminia Esteban

1.1k total citations
13 papers, 366 citations indexed

About

Herminia Esteban is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Herminia Esteban has authored 13 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Virology and 5 papers in Epidemiology. Recurrent topics in Herminia Esteban's work include HIV/AIDS Research and Interventions (8 papers), HIV Research and Treatment (7 papers) and HIV/AIDS drug development and treatment (6 papers). Herminia Esteban is often cited by papers focused on HIV/AIDS Research and Interventions (8 papers), HIV Research and Treatment (7 papers) and HIV/AIDS drug development and treatment (6 papers). Herminia Esteban collaborates with scholars based in Spain. Herminia Esteban's co-authors include Rafael Rubio, Santiago Moreno, José A. Pérez‐Molina, José Sanz, Ignacio Suárez-Lozano, Beatriz Mahíllo, Antonio Antela, Juan Pasquau, Ana Mariño and Juan González‐García and has published in prestigious journals such as Clinical Infectious Diseases, The Lancet Infectious Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Herminia Esteban

12 papers receiving 359 citations

Peers

Countries citing papers authored by Herminia Esteban

Since Specialization

Citations

This map shows the geographic impact of Herminia Esteban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herminia Esteban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herminia Esteban more than expected).

Fields of papers citing papers by Herminia Esteban

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herminia Esteban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herminia Esteban. The network helps show where Herminia Esteban may publish in the future.

Co-authorship network of co-authors of Herminia Esteban

This figure shows the co-authorship network connecting the top 25 collaborators of Herminia Esteban. A scholar is included among the top collaborators of Herminia Esteban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herminia Esteban. Herminia Esteban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	A Phase IV, Open-label, Single-Arm, Multicentric Clinical Trial for Evaluation of Human Papillomavirus 9vHPV Vaccine Immunogenicity in Men Who Have Sex With Men With HIV: GeSIDA Study 10 017 2025 ·Clinical Infectious Diseases ·Raquel Ron, C. Vanesa Díaz-García, (unknown), Alfonso Cabello, (unknown), Clara Crespillo‐Andújar, Rosa Feltes, (unknown), (unknown), Herminia Esteban, Miguel Górgolas, Santiago Moreno, José A. Pérez‐Molina, Sergio Serrano‐Villar	0
2	Changes in Quality of Sleep, Mood, and Other Neuropsychiatric Symptoms After Switching Dolutegravir/Lamivudine/Abacavir to Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Randomized Study of People With Human Immunodeficiency Virus With Poor Sleep Quality: GESIDA 10418 2022 ·Open Forum Infectious Diseases ·Alfonso Cabello, (unknown), Jesús Troya, (unknown), María Novella Mena, (unknown), Rafael Micán, Miguel Górgolas, Guillermo Cuevas, (unknown), (unknown), (unknown), Carmen Busca, (unknown), (unknown), (unknown), Herminia Esteban, Ignacio Valero	8
3	Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study) 2016 ·Journal of Antimicrobial Chemotherapy ·José A. Pérez‐Molina, Rafael Rubio, Antonio Rivero, Juan Pasquau, Ignacio Suárez-Lozano, Melchor Riera, Miriam Estébanez, Rosario Palacios, José Sanz, Jesús Troya, Ana Mariño, Antonio Antela, Jordi Navarro, Herminia Esteban, Santiago Moreno	48
4	Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial 2015 ·The Lancet Infectious Diseases ·José A. Pérez‐Molina, Rafael Rubio, Antonio Rivero, Juan Pasquau, Ignacio Suárez-Lozano, Melcior Riera, Miriam Estébanez, Jesús Santos, José Sanz, Jesús Troya, Ana Mariño, Antonio Antela, Jordi Navarro, Herminia Esteban, Santiago Moreno	87
5	Validación y cumplimentación de los indicadores de calidad GESIDA en pacientes con infección por el VIH 2015 ·Enfermedades Infecciosas y Microbiología Clínica ·Melchor Riera, Herminia Esteban, (unknown), Rosario Palacios, Fernando Lozano, José Ramón Blanco, Eulalia Valencia, Antonio Ocampo, Concha Amador, Guillem Frontera, (unknown)	5
6	Effects of Sustained Viral Response in Patients With HIV and Chronic Hepatitis C and Nonadvanced Liver Fibrosis 2014 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Juan Berenguer, (unknown), Ana Carrero, Miguel Ángel von Wichmann, Manel Crespo, José López-Aldeguer, Teresa Aldámiz‐Echevarría, Marisa Montes, Carmen Quereda, María Jesús Téllez, Marı́a José Galindo, José Sanz, Ignacio de los Santos, Josep M. Guardiola, Herminia Esteban, José M. Bellón, Juan González‐García	19
7	CNS safety at 48‐week of switching to ATV/r plus 3TC or two nucleos(t)ides in HIV‐suppressed patients on stable ART: the SALT neurocognitive sub‐study 2014 ·Journal of the International AIDS Society ·Ignacio Valero, Juan Pasquau, Rafael Rubio, (unknown), José Ramón Santos, Jesús Sanz, Ana Mariño, Manel Crespo, José L. Hernández, José Antonio Iribarren, Félix Gutiérrez, Alberto Terrón, Herminia Esteban, José A. Pérez‐Molina	5
8	Response to Combined Antiretroviral Therapy According to Gender and Origin in a Cohort of Naïve HIV-Infected Patients: GESIDA-5808 Study 2012 ·HIV Clinical Trials ·José A. Pérez‐Molina, Marta Mora-Rillo, Ignacio Suárez-Lozano, José L. Casado, (unknown), (unknown), (unknown), Asunción Hernando, Peré Domingo, (unknown), Herminia Esteban, Juan González‐García, (unknown)	11
9	Effect of simplification from protease inhibitors to boosted atazanavir‐based regimens in real‐life conditions 2010 ·HIV Medicine ·Rafael Rubio, Oscar K. Serrano, (unknown), Víctor Asensi, S Echevarrı́a, Juan Flores, Esteban Ribera, (unknown), Antonio Ocampo, B De La Fuente, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Herminia Esteban, Beatriz Mahíllo, (unknown), Juan González‐García, (unknown)	14
10	Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 Study 2010 ·Current HIV Research ·José A. Pérez‐Molina, Marta Mora-Rillo, (unknown), José L. Casado, (unknown), (unknown), (unknown), Asunción Hernando, Pere Domingo Pedrol, Ana Royuela, (unknown), Herminia Esteban, Juan González‐García	18
11	Pegylated interferon 2a plus ribavirin versus pegylated interferon 2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients 2009 ·Journal of Antimicrobial Chemotherapy ·Juan Berenguer, Juan González‐García, José López-Aldeguer, Miguel Ángel Von-Wichmann, Carmen Quereda, Asunción Hernando, José Sanz, Cristina Tural, Enrique Ortega, Josep Mallolas, Ignacio de los Santos, Pilar Miralles, Marisa Montes, José M. Bellón, Herminia Esteban, (unknown)	24
12	Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma 2007 ·Haematologica ·Blanca Xicoy, Josep‐María Ribera, Pilar Miralles, Juan Berenguer, Rafael Rubio, Beatriz Mahíllo, Eulalia Valencia, Eugènia Abella, Armando López‐Guillermo, (unknown), Mireia Morgades, José‐Tomás Navarro, Herminia Esteban, (unknown)	76
13	Estudio multicéntrico sobre prevalencia de las coinfecciones por virus de hepatitis, indicación de tratamiento de hepatitis crónica C y necesidad de trasplante hepático en pacientes infectados por el VIH en España. Estudio GESIDA 29/02-FIPSE 12185/01 2005 ·Enfermedades Infecciosas y Microbiología Clínica ·Juan González‐García, Beatriz Mahíllo, Susana Hernández, Raquel S Pacheco, Sergio Diz, (unknown), Herminia Esteban, José Ramón Arribas, Carmen Quereda, Rafael Rubio, Jesús Díez‐Manglano, Santiago Moreno, (unknown)	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact